In the Summer 2018 edition of the Royal College of Psychiatrist’s magazine, I N S I G H T, Professor David Baldwin, Chair of the College Psychopharmacology Committee gives advice on off-label prescribing:
The full article can be read here.
The following is an extract:
I would have expected this perspective, by a key opinion leader and Chair of the Royal College of Psychiatrists Psychopharmacology Committee, to include full details of any potential declarations of competing interests. However, it did not.
